merck glp-1 agonist Danuglipron: An Oral GLP-1R Competing with Peptide Injectables for Diabetes and Obesity How GLP-1 medications are transforming
Description
During acute inflammation caused by A build-up, microglia phagocytose A and protect neurons from A toxicity (47)
Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV
Obes (Silver Spring) (2012) 20(8):156671
Originally developed as pharmacological agents for the management of Type 2 diabetes mellitus, these molecules which include semaglutide, liraglutide, and tirzepatide have undergone a remarkable scientific reappraisal over the past several years
Tan says
Scale bar = 100 m
